Medical Health & Life Science Research News

Global lung cancer therapeutics market from 2016 to 2020 insights shared in detailed report

The global lung cancer therapeutics market to contribute around $11.19 billion during the period 2016-2020.

Report Global Lung Cancer Therapeutics Market 2016-2020 is a new market research publication announced by Reportstack. 

Report Outline: Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Smoking is a major cause of lung cancer, though it also occurs in non-smokers.

Lung cancer can be categorized into two major types, namely NSCLC and SCLC.

- Advertising -

- Premium. -

NSCLC is the commonest type of lung cancer and constitutes almost 85%-90% of the total diagnosed cases.

It grows and spreads quite slowly.

For detailed report with TOC, please click here ​Global Lung Cancer Therapeutics Market 2016-2020

Market Growth: The global lung cancer therapeutics market to contribute around $11.19 billion during the period 2016-2020.

Key vendors 
• F. Hofmann-La Roche
• Eli Lilly
• AstraZeneca
• Pfizer
• Celgene

Other prominent vendors 
• Abbvie
• Aetna
• Agennix
• Allergan
• Amgen
• ARIAD Pharmaceuticals
• Astellas Pharma
• Betta Pharmaceuticals
• BeyondSpring Pharmaceuticals
• BioNumerik Pharmaceuticals
• Boehringer Ingelheim
• Boston Biomedical
• Bristol-Myers Squibb
• Celldex
• CTI BioPharma
• Eisai
• GlaxoSmithKline
• GTx
• Helsinn
• Hutchison Medipharma
• Ionis Pharmaceuticals
• Kadmon Corporation
• MabVax
• Merck
• Novartis
• NovaRx Corporation
• OncoGeneX
• Ono Pharmaceutical
• OSE Immunotherapeutics
• OSI Pharmaceuticals
• Peregrine
• PharmaMar
• Pierre Fabre
• Qiagen
• Recombio
• Samsung Bioepis
• Sanofi
• SFJ Pharmaceuticals
• Spectrum Pharmaceuticals
• Sumitomo Dainippon Pharma
• Synta
• Takeda Pharmaceuticals
• Teva Pharmaceutical
• Xcovery

Regions Covered: 

• Americas
• APAC
• EMEA

Companies Mentioned

F. Hofmann-La Roche, Eli Lilly, AstraZeneca, Pfizer, Celgene, Abbvie, Aetna, Agennix, Allergan, Amgen, ARIAD Pharmaceuticals, Astellas Pharma, Betta Pharmaceuticals, BeyondSpring Pharmaceuticals, BioNumerik Pharmaceuticals, Boehringer Ingelheim, Boston Biomedical, Bristol-Myers Squibb, Celldex, CTI BioPharma, Eisai, GlaxoSmithKline, GTx, Helsinn, Hutchison Medipharma, Ionis Pharmaceuticals, Kadmon Corporation, MabVax, Merck, Novartis, NovaRx Corporation, OncoGeneX, Ono Pharmaceutical, OSE Immunotherapeutics, OSI Pharmaceuticals, Peregrine, PharmaMar, Pierre Fabre, Qiagen, Recombio, Samsung Bioepis, Sanofi, SFJ Pharmaceuticals, Spectrum Pharmaceuticals, Sumitomo Dainippon Pharma, Synta, Takeda Pharmaceuticals, Teva Pharmaceutical, Xcovery.

...